Perspective Therapeutics, Inc. (CATX) financial statements and ratios from SEC XBRL: revenue $8.11M (TTM), net margin -1270.9%, revenue growth -22.8% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $8.11M |
| Net Margin | -1270.9% |
| Revenue Growth (YoY) | -22.8% |
| EPS Growth (YoY) | 13.8% |
| FCF Growth (YoY) | 31.0% |
| Price / Book | 1.16 |
| Price / Sales | 43.31 |
| FCF Yield | -57.2% |
| Altman Z-Score | 1.17 (distress) |
| Sector P/E (Healthcare) | 21.7 |
CATX overview · CATX earnings · CATX KPIs · CATX investor relations · CATX ownership · CATX peers · CATX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.